Medtronic price target raised to $98 from $95 at Mizuho

Mizuho raised the firm’s price target on Medtronic to $98 from $95 and keeps a Buy rating on the shares. The company’s fiscal Q3 report “hit the market in all the right places,” the analyst tells investors in a research note. The firm says Medtronic’s margin expansion has legs but currency and inflation remain an offset. It believes the company’s revamped portfolio will outweigh 2024 headwinds.